Coocooburra recieved another email from Nader. Nader confirmed that they will be working to compile the data in the mild to moderate so they can lock and unblind the data. They need to not rush this piece as it's the most critical step in the process. (Confirmed the mid July target)

He also said that they are not timing the release of the two sets of trial data as the SEC requires timely delivery of material information (they are not allowed to sit on it)

Lastly in response to a question about concerns of other drugs beating us to market he said they are not concerned about that because the world needs our MOA and if other drugs can also help "God bless them."